> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Acthar Gel Withdrawn Over Safety/Effectiveness
- URL: https://www.fdaweb.com/acthar-gel-withdrawn-over-safety-effectiveness/
- Published: 2017-01-23T12:00:00.000Z
- Updated: 2026-09-14T22:02:17.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137792

*Federal Register* Notice: FDA has determined that Acthar Gel Synthetic (seractide acetate) injection, 80 units/milliliter (mL) and 40 units/mL, was withdrawn from sale for reasons of safety or effectiveness. The agency will not accept or approve ANDAs that reference the product because of this determination. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-01-23/pdf/2017-01249.pdf?ref=fdaweb.com).